Think

New Obesity Drugs Come With a Side Effect of Shaming

Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority

Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles.

Vaccine Makers Kept $1.4 Billion in Prepayments for Canceled Covid Shots for the World’s Poor

F.D.A. Panel Recommends Pulling Preterm Birth Drug From the Market

Abortion Pill Providers Experiment With Ways to Broaden Access

There’s Just One Drug to Treat Monkeypox. Good Luck Getting It.

Fentanyl From the Government? A Vancouver Experiment Aims to Stop Overdoses

After Roe, Pregnant Women With Cancer Diagnoses May Face Wrenching Choices

New Dementia Prevention Method May Be Behavioral, Not Prescribed

When Abortion Pills Were Banned in Brazil, Women Turned to Drug Traffickers

New Experimental Therapy for A.L.S. Approved in Canada

Ivermectin Does Not Shorten Recovery Time From Covid, Study Finds

21 Americans Infected With Monkeypox, C.D.C. Reports

Abortion Pills Stand to Become the Next Battleground in a Post-Roe America

Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials

Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug

New A.L.S. Treatment Lacks Evidence of Benefit, F.D.A. Panel Finds

Ivermectin Does Not Reduce Risk of Covid Hospitalization, Large Study Finds

F.D.A. Nominee Faces Steep Climb to Senate Confirmation